Charco Neurotech

17/09/2026

MYTH vs EVIDENCE: Parkinson’s symptom management 🧠

MYTH: There’s nothing you can do about Parkinson’s symptoms.
EVIDENCE: While there’s currently no cure for Parkinson’s, symptoms can be managed in a number of ways, including medication, physiotherapy, occupational therapy, exercise and other supportive treatments.

MYTH: Parkinson’s is just about tremor.
EVIDENCE: Parkinson’s can affect movement in many different ways, including stiffness, slowness, balance and gait as well as a wide range of non-motor symptoms.

MYTH: Medication is the only way to manage symptoms.
EVIDENCE: Medication is an important part of treatment, but it can sit alongside other solutions.

MYTH: If something is a Parkinson’s symptom, it must be Parkinson’s itself.
EVIDENCE: Some changes can be related to medication side effects, too. That’s why tracking symptoms and discussing changes with your Parkinson’s team is so important.

Parkinson’s is complex and symptom management shouldn’t be one-size-fits-all.

Understanding what’s happening, tracking changes and working with your healthcare team can help you find the right combination of support for you.

10/09/2026

At Charco Neurotech, understanding the challenges the Parkinson’s community face comes before everything else.

Every conversation we have, every piece of research we undertake and every product decision we make starts with one question:

How can we better support people living with Parkinson’s?

Because Parkinson’s isn’t just what we work on. It’s why we exist.

07/09/2026

Parkinson’s is the fastest-growing neurological condition globally.

Created alongside the Parkinson’s community, CUE1+ combines neuroscience, engineering and clinical research to support the management of key motor symptoms including stiffness, balance, gait and tremor.

Using research-backed targeted stimulation, CUE1+ is designed to help people move with greater confidence and independence in everyday life.

Move more freely. Live more fully. With Charco.

Have questions about CUE1+? Ask us in the comments.

03/09/2026

The CUE+1 Device is trusted by more than 3,000 people every single day.

But 3,000 isn’t just a number.

It’s 3,000+ mornings.

3,000+ first cups of tea.
3,000+ walks.
3,000+ conversations.
3,000+ getting dressed.
3,000+ trips to the shops.
3,000+ ordinary moments that make up a day.

Because behind every number is a person.

And behind every person is a life that goes far beyond Parkinson’s.

31/08/2026

The true impact of the CUE1+ is best told by those who use it. Here’s one customer’s experience of the difference it’s made every day.

27/08/2026

Balance & Postural Instability, Supporting confidence in movement.

Changes in balance can increase the risk of falls and reduce confidence in everyday movement.

Managing balance usually involves:

• Physiotherapy
• Strength and balance exercises
• Medication review
• Falls prevention strategies

The CUE1+ has been developed to complement these approaches by providing continuous sensory cueing that supports movement throughout the day.

Clinical studies found users experienced an average 12-point improvement in MDS-UPDRS Part III, indicating improvements across multiple motor symptoms.

24/08/2026

21/08/2026

Walking Changes in Parkinson’s

For many people living with Parkinson’s, changes in walking can have one of the biggest impacts on everyday life.

These changes may include:

Smaller steps
Slower walking
Reduced arm swing
Freezing of gait
Clinical guidelines recognise external cueing as an effective strategy for helping many people improve their walking and movement.

The CUE1+ delivers continuous vibrotactile cueing throughout the day, providing rhythmic sensory stimulation designed to support movement alongside your existing Parkinson’s treatment plan.

Our case study shows a considerable improvement in gait, including reduced freezing of gait in the device-on state compared with device-off state.

When movement improves, the impact goes beyond walking, improving your confidence, giving you more independence and more in control of your daily life.
If walking felt smoother, steadier or more natural, what difference would that make to your everyday life?

17/08/2026

Parkinson’s is the fastest-growing neurological condition globally.

The CUE1+ was created alongside and for the Parkinson’s community, combining neuroscience, engineering and clinical research to support people living with Parkinson’s.

Using research-backed targeted stimulation, the CUE1+ is designed to support the management of key motor symptoms, including rigidity (stiffness), changes in balance, gait and tremor.

By helping people move with greater confidence and independence, CUE1+ aims to support everyday quality of life.

Move more freely. Live more fully. With Charco.

Have questions about the CUE1+?
Ask us anything in the comments below.

12/08/2026

Thanks to Parkinson's UK for sharing this 🙏

Results from a small clinical trial of CUE1+ has shown it's safe and has the potential to help manage movement symptoms of Parkinson's.

CUE1+ was developed by a company called .neurotech. It's a small, chest-mounted, device that delivers rhythmic vibrations throughout the day. To understand the potential benefits, researchers at carried out a trial involving 50 people with Parkinson's. The results suggest that the device was safe and easy to use, and may have the potential to improve movement symptoms, particularly slowness of movement, in people with Parkinson's.